America’s biopharmaceutical companies to Congress: Government “negotiation” is the wrong approach

Today, PhRMA member companies made public an open letter to Capitol Hill to encourage Congress to abandon old partisan ideas on drug pricing and instead pursue policies that actually address what patients pay out of pocket. As the members state in their letter: